Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,167,470
-
Share change
-
+12,758,966
-
Total reported value
-
$298,733,200
-
Price per share
-
$23.04
-
Number of holders
-
54
-
Value change
-
+$289,321,200
-
Number of buys
-
49
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2014
As of 31 Dec 2014,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,167,470 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, Citadel Advisors LLC, SABBY MANAGEMENT, LLC, SPHERA FUNDS MANAGEMENT LTD., and PointState Capital LP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.